AMERICAN EPILEPSY SOCIETY
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$20,305,116
Investments
77%
Cash & Equivalents
19%
Prepaid Expenses
2%
Other Assets
1%
Receivables (Non-Related)
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$2,251,019
Deferred Revenue
73%
Payables & Accruals
18%
Other Liabilities
9%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$3,260,945
$3,809,803
+17%
Receivables (Non-Related)
$626,611
$137,967
-78%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$452,110
$433,736
-4%
Investments
$14,342,757
$15,612,947
+9%
Property, Plant, & Equipment (net)
$197,347
$94,131
-52%
Other Assets
$452,400
$216,532
-52%
Total Assets
$19,332,170
$20,305,116
+5%
Liabilities
2023
2024
Change
Payables & Accruals
$440,027
$408,319
-7%
Grants Payable
-
-
-
Deferred Revenue
$1,551,086
$1,647,040
+6%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$447,518
$195,660
-56%
Total Liabilities
$2,438,631
$2,251,019
-8%
Net assets
2023
2024
Change
Restricted Net Assets
$6,635,806
$6,878,727
+4%
Unrestricted Net Assets
$10,257,733
$11,175,370
+9%
Net assets
2023
2024
Change
Net assets
+$16,893,539
+$18,054,097
+7%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)